Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development-Reference-Cited by-同舟云学术

Statins potentiate thein vitroanti-hepatitis C virus activity of selective hepatitis C virus inhibitors and delay or prevent resistance development

Published:2009-02-18 Issue:1 Volume:50 Page:6-16
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Delang Leen,Paeshuyse Jan,Vliegen Inge,Leyssen Pieter,Obeid Susan,Durantel David,Zoulim Fabien,Op de Beeck Anne,Neyts Johan

Publisher

Wiley

Subject

Hepatology

Reference42 articles.

1. Clinical consequences of hepatitis C virus infection;Zoulim;Rev Med Virol,2003

2. Old and emerging therapies in chronic hepatitis C: an update;Deutsch;J Viral Hepat,2008

3. Antiviral efficacy of NS3-serine protease inhibitor BILN-2061 in patients with chronic genotype 2 and 3 hepatitis C;Reiser;HEPATOLOGY,2005

4. Selective inhibitors of hepatitis C virus replication;Neyts;Antiviral Res,2006

5. Efficacy and safety of valopicitabine in combination with pegylated interferon-α (PEG IFN) and ribavirin (RBV) in patients with chronic hepatitis C;Poordad;HEPATOLOGY,2007

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic and pharmacological perturbation of hepatitis-C virus entry;Current Opinion in Virology;2023-10

2. Oncogenic viruses and host lipid metabolism: a new perspective;Journal of General Virology;2023-06-06

3. Host Cell Targets for Unconventional Antivirals against RNA Viruses;Viruses;2023-03-17

4. Can statins lessen the burden of virus mediated cancers?;Infectious Agents and Cancer;2022-09-04

5. A Meta-Analysis of Statin Use and Risk of Hepatocellular Carcinoma;Canadian Journal of Gastroenterology and Hepatology;2022-03-20